News List
Novartis‘s Multiple sclerosis Innovative drug approved
2019-03-29
Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for the treatment of recur
Highly efficient trifluoromethylation and [18F]trifluoromethylation
2019-03-02
Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, has created a new trif
Redox neutral [4+1] cyclic reaction based on C-F fracture
2019-01-19
Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Technology and Professor R
FDA accelerates approval of no-limit cancer targeting therapy for the treatment of NTRK fusion tumors
2018-12-15
Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a co-developed VITRAKVI
FDA approves new mechanism for listing new anti-influenza drugs
2018-11-17
Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil), jointly developed
FDA grants Relacorilant the qualification for orphan drugs for pancreatic cancer
2018-10-20
Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate of 5%. In the United
For the first time, scientists have discovered fluorine in natural conditions
2018-09-20
Fluorine is the most reactive chemical element. That is why it is not found in nature in its elemental form, but only in
Fluorinated antimalarial drug tafenoquine (Krintafel) approved by the US FDA
2018-08-15
Recently, British pharmaceutical giant GlaxoSmithKline (GSK) announced that the fluorogenic anti-malarial drug tefenoqui
Sanofi is approved the listing of rare disease drugs in China
2018-07-30
Sanofi is approved in China for the treatment of a new drug for relapsing multiple sclerosis, Obajie (Terifluide tablets
Why can fluorine-substituted conjugated polymers improve the efficiency of organic solar cells?
2018-07-16
Today, with the increasing consumption of energy, research on solar cells has attracted more and more attention. Compare